Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ipsen discontinues development of irosustat as monotherapy

June 8, 2011

Tekmira secures licenses to two validated oncology targets from Alnylam Pharmaceuticals

June 8, 2011

Plexxikon presents novel protein kinase inhibitors

June 8, 2011

New tubulin inhibitors synthesized by R&D-Biopharmaceuticals

June 8, 2011

Sunitinib has limited efficacy in advanced adrenocortical carcinoma in phase II trial

June 8, 2011

Plexxikon provides update on vemurafenib development program

June 7, 2011

GSK presents new serine/threonine-protein kinase B-raf inhibitors

June 7, 2011

Interim first-in-human data suggest MK-1496 is active against solid tumors

June 7, 2011

Mologen to investigate DNA immunomodulator MGN-1703 in lung cancer

June 7, 2011

Algeta to stop phase III ALSYMPCA trial of Alpharadin based on statistically significant efficacy

June 6, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.